Elsayed Balbaa: Baseline Anemia Predicts Adverse 12-Month Outcomes After Elective PCI for Stable CAD
Elsayed Balbaa, Student of Alexandria University, shared a post on LinkedIn:
“A new Publication!
We found that in men undergoing first-time elective PCI for stable CAD, baseline anemia was associated with higher 12-month risks of AKI, major bleeding, need for transfusion, hospitalization, and death, especially with recent (≤ 1 year) bleeding or transfusion history.”
Mohamed R. Murad, Bachelor of Medicine, Bachelor of Surgery – MBBS at Al-Azhar University, shared a post on LinkedIn:
“Pleased to share our recent publication:
‘Prognostic Impact of Baseline Anemia on Outcomes After Elective PCI in Men: A US Retrospective Cohort Study.’
In this study, we examined the prognostic impact of baseline anemia on outcomes after elective PCI in men with stable coronary artery disease.
Our analysis incorporated survival analysis, Kaplan-Meier curves, log-rank testing, univariable and multivariable Cox proportional hazards regression, propensity score matching, falsification (negative-control) endpoint analysis, E-value sensitivity analysis, and multiple-testing adjustment using Benjamini-Hochberg and Bonferroni methods.
I’m truly happy to be part of this great work with such outstanding leaders, collaborators, and team members.
I’m deeply grateful for the guidance, dedication, and shared effort of all co-authors who contributed to this study.
Proud to contribute to research that advances clinical understanding and supports better patient care.”
Title: Catheterization and Cardiovascular Interventions
Authors: Abdalhakim Shubietah, Mohamed S. Elgendy, Mohamed Saad Rakab, Ahmed Ahmed, Batoul Abusalah, Mohamed R. Murad, Belal Mohamed Hamed, Hamza A. Abdul-Hafez, Ahmed Emara, Qutaiba Qafisheh, Elsayed Balbaa, Ameer Awashra, Ahmed Mansour, Ahmed Elbataa, Abdalrahman Assaassa, Mohammed Mhanna
Read the Article on Catheterization and Cardiovascular Interventions

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series